Nestlé agrees to buy peanut allergy treatment maker for $2.6B August 31, 2020 admin Trading Ideas Comments Off on Nestlé agrees to buy peanut allergy treatment maker for $2.6B Nestlé paid $2.6 billion to gain ownership of Aimmune Treatment. Yahoo Finance’s On The Move panel share the details. …read more Source:: Yahoo Finance Did you enjoy this article? Join our FREE Newsletter! Thank you for subscribing. Something went wrong. I agree to have my personal information transfered to MailChimp ( more information ) Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.We hate spam. Your email address will not be sold or shared with anyone else.